1. Home
  2. CBZ vs PGEN Comparison

CBZ vs PGEN Comparison

Compare CBZ & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBIZ Inc.

CBZ

CBIZ Inc.

HOLD

Current Price

$32.94

Market Cap

1.7B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.17

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBZ
PGEN
Founded
1987
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
CBZ
PGEN
Price
$32.94
$4.17
Analyst Decision
Hold
Buy
Analyst Count
3
5
Target Price
$41.33
$8.33
AVG Volume (30 Days)
804.2K
3.6M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
134.62
N/A
EPS
1.83
N/A
Revenue
$922,003,000.00
$230,981,000.00
Revenue This Year
$3.92
$1,115.92
Revenue Next Year
$4.12
$81.04
P/E Ratio
$17.82
N/A
Revenue Growth
7.79
N/A
52 Week Low
$24.29
$1.23
52 Week High
$77.91
$5.47

Technical Indicators

Market Signals
Indicator
CBZ
PGEN
Relative Strength Index (RSI) 67.77 56.45
Support Level $24.87 $3.97
Resistance Level $54.79 $4.40
Average True Range (ATR) 1.33 0.22
MACD 0.42 0.00
Stochastic Oscillator 85.38 64.04

Price Performance

Historical Comparison
CBZ
PGEN

About CBZ CBIZ Inc.

CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: